ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs

Endocr Relat Cancer. 2024 Jul 25;31(9):x240043. doi: 10.1530/ERC-24-0043e.
No abstract available

Publication types

  • Published Erratum

MeSH terms

  • Human Growth Hormone* / analogs & derivatives
  • Humans
  • Neuroendocrine Tumors / drug therapy
  • Neuroendocrine Tumors / metabolism
  • Pituitary Neoplasms / drug therapy
  • Pituitary Neoplasms / metabolism
  • Prolactin* / blood
  • Prolactin* / metabolism
  • Somatostatin* / analogs & derivatives
  • Somatostatin* / therapeutic use

Substances

  • Somatostatin
  • pasireotide
  • pegvisomant
  • Prolactin
  • Human Growth Hormone